Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Flatiron Health

Biotech & Life Sciences · New York City, United States · Founded 2012 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
1–2k
Current team size
Unlock exact value

Oncology real-world data and evidence generation platform

Investors

20 investors on Flatiron Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 17 investors entered at this stage
Series B+ 3 investors entered at this stage
Roche Venture Fund
Allen & Company
Roche

Global footprint

Where Flatiron Health has talent and traffic

AI talent share
3.8% of workforce is AI talent
(56 of 1,466 staff)
Core AI130.89%
Other AI432.93%
Non-AI workforce1,41096.18%
Workforce by country
10 countries with
team presence
🇺🇸 United States92.2%
🇬🇧 United Kingdom3.4%
🇩🇪 Germany2.2%
🇯🇵 Japan1.4%
🇮🇳 India0.2%
Top 5 of 10 shown
Web traffic by country
650K monthly visits
across markets
🇺🇸 United States92.7%
🇮🇳 India1.9%
🏳️ Puerto Rico0.9%
🇮🇪 Ireland0.6%
🇬🇧 United Kingdom0.5%
Top 5 markets shown

Patent intelligence

$8M patent portfolio · 34 active families

Estimated portfolio value
$8M
0.43% of valuation · 114.6× smaller than top peer Globus Medical ($930M)
34 active patent families
Where Flatiron Health innovates Data scienceData miningMedicineData libraryMedical record

Where Flatiron Health concentrates vs peers

Each axis is a top-10 topic across Flatiron Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Flatiron Health's 6 investments and acquisitions.

Every disclosed deal where Flatiron Health appeared as a backer or acquirer, 2018–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Flatiron Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Flatiron Health deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Flatiron Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Sentiment on X

        What X is saying about Flatiron Health

        An AI-synthesized read of the highest-engagement posts about Flatiron Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Flatiron Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.